Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview

6115studies shown

Showing 4,945-4,956 of 6,115

CompletedNCT00590265

Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Montreal

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionBehavioralFrom 18 Years to 70 Years

Countries: Canada
Sponsor: Douglas Mental Health University Institute
Condition: Bipolarity, Depression

View study

CompletedNCT00790738

Liothyronine (T3) for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Glen Oaks

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Northwell Health
Condition: Bipolarity, Depression

View study

TerminatedNCT00217217

Low Field Magnetic Stimulation Treatment for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Belmont

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDeviceFrom 18 Years to 70 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Bipolarity, Depression

View study

CompletedNCT03249376

Lumateperone Monotherapy for Depression in bipolarity Conducted Globally

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, Bulgaria, Colombia, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, France, Canada, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT00868452

Lurasidone - A 6-week Study of people with Bipolar I Depression (Add-on)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, France, Czechia, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT00868699

Lurasidone - A 6-week Study of people with Bipolar I Depression (Monotherapy)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Escondido

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, France, Czechia, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT01284517

Lurasidone HCI - A 6-week Phase 3 Study of people with Bipolar I Depression

This study is completed in the United States, in Canada, in Colombia, .... It focuses on depression.

Multiple locations, including Costa Mesa

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, Canada, Colombia, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Dothan

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 10 Years to 17 Years

Countries: United States, France, Bulgaria, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

View study

Active Not RecruitingNCT06350201

Machine Learning-based Classification of Symptom Clusters and Online CBT

This summary needs review. Please check the official study record and contact the research team for details.

In Wuhan

Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionBehavioralFrom 18 Years to 64 Years

Countries: China
Sponsor: Wuhan Mental Health Centre
Condition: Anxiety, Depression

View study

TerminatedNCT01051440

Magnetic Resonance Imaging Study of Lisdexamfetamine for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Boston

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 21 Years to 50 Years

Countries: United States
Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT00183469

Maintenance Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugOver 18 Years

Countries
Sponsor: The University of Texas Health Science Center at San Antonio
Condition: Bipolarity, Depression

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.